Security key
75382E109
RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT)
CUSIP: 75382E109
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 27,725,634
- Total 13F shares
- 1,341,050
- Share change
- -129,765,896
- Total reported value
- $10,728,400
- Reported price per share
- $8.00
- Number of holders
- 2
- Value change
- -$158,903,455
- Number of sells
- 86
Security identity
Holder snapshot
Report period
Q2 2025
Institutions
2
Top holders
2
RAPT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
RAPT Therapeutics, Inc. SEC filings
RAPT Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75382E109
Recent filing periods:
Ownership snapshot
Top reported holders of RAPT - RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Medicxi IV LP
13D/G signal
Medicxi IV LP
Evidence rows
15
Latest as of
30 Jun 2025
13D/G
13F
3/4/5
Lead comparable stake: 17%
13D/G row: Medicxi IV LP
Showing 1-6 of 15 holder rows.
Rank 1 holder
Medicxi IV LP
13D/G
- Ownership
- 17%
- Position
- $19.45M
Rank 2 holder
TCG Crossover GP II, LLC
13D/G
- Ownership
- 10%
- Position
- $11.48M
Rank 3 holder
Redmile Group, LLC
13D/G
13F
- Ownership
- 9.9%
- Position
- $14.93M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Medicxi IV LP |
13D/G
Medicxi IV GP Limited
|
17%
|
$19,446,240
22,352,000 shares
|
$0 | 27 Dec 2024 |
| TCG Crossover GP II, LLC |
13D/G
|
10%
|
$11,478,006
13,193,110 shares
|
$0 | 27 Dec 2024 |
| Redmile Group, LLC |
13D/G
13F
Company
|
9.9%
|
$14,934,463
1,765,303 shares
|
$0 | 30 Jun 2025 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
9.9%
|
$12,280,920
14,116,000 shares
|
$0 | 23 Dec 2024 |
| Foresite Capital Fund VI LP |
13D/G
Foresite Capital Fund VI, L.P.
|
9.3%
|
$10,875,000
12,500,000 shares
|
$0 | 23 Dec 2024 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
6.3%
from 13D/G
|
$10,100,133
8,278,798 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
1,341,050
Rows available
2
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
89
Q2 2025 holders
2
Holder diff
-87
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend